MiR-744-5p Inducing Cell Death by Directly Targeting HNRNPC and NFIX in Ovarian Cancer Cells

Scientific Reports - United Kingdom
doi 10.1038/s41598-018-27438-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

miR-296-5p Suppresses Cell Viability by Directly Targeting PLK1 in Non-Small Cell Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2015English

miR‑106b‑5p Promotes Cell Proliferation and Cell Cycle Progression by Directly Targeting CDKN1A in Osteosarcoma

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2020English

MicroRNA‑744 Suppresses Cell Proliferation and Invasion of Papillary Thyroid Cancer by Directly Targeting NOB1

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Suppressing Cell Growth and Inducing Apoptosis by Inhibiting miR‑23a‑5p in Human Bladder Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

MiR–20a-5p Promotes Radio-Resistance by Targeting Rab27B in Nasopharyngeal Cancer Cells

Cancer Cell International
Cancer ResearchOncologyGenetics
2017English

miR–483-5p Promotes Prostate Cancer Cell Proliferation and Invasion by Targeting RBM5

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2017English

miR-625 Reverses Multidrug Resistance in Gastric Cancer Cells by Directly Targeting ALDH1A1

Cancer Management and Research
Oncology
2019English

Downregulation of miR-145-5p in Cancer Cells�and Their�derived Exosomes May Contribute To�the�development of Ovarian Cancer by Targeting CT

International Journal of Molecular Medicine
MedicineGenetics
2018English

PVT1- Derived miR-1207-5p Promotes Breast Cancer Cell Growth by Targeting STAT6

Cancer Science
Cancer ResearchMedicineOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy